Gsk (GSK) Net Income (2009 - 2026)
Gsk (GSK) reported Net Income of $3.21 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Net Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 8, 2026, Gsk's Net Income came in at $3.05 billion; for the year ended Dec 31, 2025, it was $8.29 billion, up 119.8% from the prior year.
- Net Income has a five-year compound annual growth rate of 0.2% (years ended Dec 2020 to Dec 2025).
- By year, Net Income came in at $3.77 billion in the year ended Dec 31, 2024 (-42.9%), $6.6 billion in the year ended Dec 31, 2023 (-65.8%), $19.33 billion in the year ended Dec 31, 2022 (+175.7%) and $7.01 billion in the year ended Dec 31, 2021 (-14.5%).
- Five-year quarterly Net Income spans a low of -$2.85 billion in the quarter ended Dec 31, 2025 and a high of $14.46 billion in the quarter ended Dec 31, 2022.
- Year over year, Net Income gained in four of the last five quarters, with growth averaging 8.9%.
- The high point for year-over-year Net Income in five years was the quarter ended Sep 30, 2022 (growth of 578.6%); the low point was the quarter ended Dec 31, 2023 (a decline of 96.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 207.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 207.96 Mn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | -2.85 Bn |
| Sep 30, 2025 | 3.74 Bn |
| Jun 30, 2025 | 2.84 Bn |
| Mar 31, 2025 | 2.23 Bn |
| Dec 31, 2024 | 643.03 Mn |
| Sep 30, 2024 | 81.86 Mn |
| Jun 30, 2024 | 2.13 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 2.68 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | -5.32 Bn |
| Sep 30, 2022 | 12.78 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.98 Bn |
| Dec 31, 2021 | 9.35 Bn |
| Sep 30, 2021 | 1.89 Bn |
API Access
Gsk Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();